EpCAM Mouse Monoclonal Antibody [3-E1-E2]
Usd: 350 Special Discount
Specification
Catalog# EM1111
EpCAM Mouse Monoclonal Antibody [3-E1-E2]
-
WB
-
IF-Cell
-
Human
-
Mouse
-
unconjugated
Safety datasheet
Overview
Product Name
EpCAM Mouse Monoclonal Antibody [3-E1-E2]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Recombinant protein within human EP-CAM aa 24-265 (Extracellular).
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell
Molecular Weight
Predicted band size: 35 kDa
Positive Control
Hela cell lysate, NIH/3T3 cell lysate, MCF-7 cell lysate, D3, A431.
Conjugation
unconjugated
Clone Number
3-E1-E2
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgM
Purification Method
Protein L affinity purified.
Application Dilution
-
WB
-
1:1,000-1:2,000
-
IF-Cell
-
1:100-1:200
Target
Function
Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein mediating Ca2+-independent homotypic cell-cell adhesion in epithelia. EpCAM is also involved in cell signaling, migration, proliferation, and differentiation. Additionally, EpCAM has oncogenic potential via its capacity to upregulate c-myc, e-fabp, and cyclins A & E. Since EpCAM is expressed exclusively in epithelia and epithelial-derived neoplasms, EpCAM can be used as diagnostic marker for various cancers. It appears to play a role in tumorigenesis and metastasis of carcinomas, so it can also act as a potential prognostic marker and as a potential target for immunotherapeutic strategies. Mutations in EpCAM have also been associated with congenital tufting enteropathy which causes intractable diarrhea in newborn children.
Background References
1. "The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation." Muenz M., Kieu C., Mack B., Schmitt B., Zeidler R., Gires O. Oncogene 23:5748-5758(2004)
2. "The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7." Ladwein M., Pape U.F., Schmidt D.S., Schnoelzer M., Fiedler S., Langbein L., Franke W.W., Moldenhauer G., Zoeller M. Exp. Cell Res. 309:345-357(2005)
3. "Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM." Munz M., Fellinger K., Hofmann T., Schmitt B., Gires O. Front. Biosci. 13:5195-5201(2008)
4. "Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells." Ng V.Y., Ang S.N., Chan J.X., Choo A.B. Stem Cells 28:29-35(2010)
Sequence Similarity
Belongs to the EPCAM family.
Tissue Specificity
Highly and selectively expressed by undifferentiated rather than differentiated embryonic stem cells (ESC). Levels rapidly diminish as soon as ESC's differentiate (at protein levels). Expressed in almost all epithelial cell membranes but not on mesodermal or neural cell membranes. Found on the surface of adenocarcinoma.
Post-translational Modification
Hyperglycosylated in carcinoma tissue as compared with autologous normal epithelia. Glycosylation at Asn-198 is crucial for protein stability.
Subcellular Location
Cell membrane
Synonyms
17 1A antibody
323/A3 antibody
Adenocarcinoma associated antigen antibody
Adenocarcinoma-associated antigen antibody
Antigen identified by monoclonal antibody
AUA1 antibody
AUA1 antibody
CD326 antibody
CD326 antigen antibody
Cell surface glycoprotein Trop 1 antibody
Expand17 1A antibody
323/A3 antibody
Adenocarcinoma associated antigen antibody
Adenocarcinoma-associated antigen antibody
Antigen identified by monoclonal antibody
AUA1 antibody
AUA1 antibody
CD326 antibody
CD326 antigen antibody
Cell surface glycoprotein Trop 1 antibody
Cell surface glycoprotein Trop 2 antibody
Cell surface glycoprotein Trop-1 antibody
CO 17A antibody
CO17 1A antibody
CO17A antibody
DIAR5 antibody
EGP 2 antibody
EGP antibody
EGP2 antibody
EGP314 antibody
EGP40 antibody
Ep CAM antibody
Ep-CAM antibody
EPCAM antibody
EPCAM_HUMAN antibody
EpCAM1 antibody
Epithelial cell adhesion molecule antibody
Epithelial Cell Adhesion Molecule Intracellular Domain (EpCAM-ICD) antibody
Epithelial cell surface antigen antibody
Epithelial cellular adhesion molecule antibody
Epithelial glycoprotein 1 antibody
Epithelial glycoprotein 314 antibody
Epithelial glycoprotein antibody
ESA antibody
GA733 1 antibody
GA733 2 antibody
GA733-2 antibody
gastrointestinal tumor-associated antigen 2, 35-KD glycoprotein antibody
gp4 antibody
hEGP 2 antibody
hEGP314 antibody
HNPCC8 antibody
Human epithelial glycoprotein 2 antibody
KS 1/4 antigen antibody
KS1/4 antibody
KSA antibody
Ly74 antibody
Lymphocyte antigen 74 antibody
M1S 1 antibody
M1S2 antibody
M4S1 antibody
Major gastrointestinal tumor associated protein GA733 2 antibody
Major gastrointestinal tumor-associated protein GA733-2 antibody
mEGP314 antibody
Membrane component chromosome 4 surface marker (35kD glycoprotein) antibody
Membrane component, chromosome 4, surface marker 1 antibody
Membrane component, chromosome 4, surface marker antibody
MIC18 antibody
MK 1 antibody
Protein 289A antibody
TACD1 antibody
TACSTD1 antibody
TROP1 antibody
Tumor associated calcium signal transducer 1 antibody
Tumor associated calcium signal transducer 2 precursor antibody
Tumor-associated calcium signal transducer 1 antibody
CollapseImages
-
Western blot analysis of EpCAM on different lysates using anti- EpCAM antibody at 1/1000 dilution.
Positive control:
Lane 1: Hela cell lysate
Lane 2: NIH/3T3 cell lysate
Lane 3: MCF-7 cell lysate -
ICC staining EpCAM in D3 cells (red). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
ICC staining EpCAM in A431 cells (green). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
Immunocytochemistry analysis of NIH/3T3 cells labeling EpCAM with Mouse anti-EpCAM antibody (EM1111) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-EpCAM antibody (EM1111) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Chemotaxis-driven hybrid liposomes recover intestinal homeostasis for targeted colitis therapy
Journal: Journal Of Controlled Release
DOI: 10.1016/j.jconrel.2025.02.036
IF: 10.5
Application: IF-tissue
Reactivity: Mouse
Publish date: 2025 Feb
-
Rapid Detection and Purification of Extracellular Vesicles for Hepatocellular Carcinoma Screening Using a Plasmonic Metasurface Integrated with the Kolmogorov–Arnold Network
Journal: ACS Applied Nano Materials
DOI: 10.1021/acsnano.5c11740
IF: 16
Application: WB
Reactivity:
Publish date: 2025 Dec
-
TNFSF11/TNFRSF11A Axis Amplifies HDM-Induced Airway Remodeling by Strengthening TGFβ1/STAT3 Action
Journal: Allergy Asthma & Immunology Research
DOI:
IF: 4.1
Application: IF-cell
Reactivity: Human,Mouse
Publish date: 2024 Jul
-
SIX1 amplification modulates stemness and tumorigenesis in breast cancer
Journal: Journal Of Translational Medicine
DOI:
IF: 7.4
Application: WB
Reactivity: Human
Publish date: 2023 Nov
-
Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
Journal: Chinese Medical Journal
DOI:
IF: 6.1
Application: IHC-P
Reactivity: Human
Publish date: 2023 May
-
The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response
Journal: Cancer Research
DOI:
IF: 13.312
Application: IF-cell
Reactivity: Human
Publish date: 2023 Jun
-
AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma
Journal: Frontiers In Pharmacology
DOI:
IF: 5.988
Application: MIHC
Reactivity: Mouse
Publish date: 2022 Oct
Products with the same target and pathway
EpCAM Mouse Monoclonal Antibody [7E11]
Application: WB,IHC-P,ELISA
Reactivity: Human
Conjugate: unconjugated
EpCAM Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
EpCAM Recombinant Rabbit Monoclonal Antibody [PS01-69] - BSA and Azide free
Application: IHC-P,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
EpCAM Rabbit Polyclonal Antibody
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 555 Conjugated EpCAM Recombinant Rabbit Monoclonal Antibody [PS01-69]
Application: FC
Reactivity: Human
Conjugate: iFluor™ 555
iFluor™ 647 Conjugated EpCAM Recombinant Rabbit Monoclonal Antibody [PS01-69]
Application: FC,IF-Cell
Reactivity: Human
Conjugate: iFluor™ 647
EpCAM Recombinant Rabbit Monoclonal Antibody [SU03-32]
Application: WB,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
EpCAM Recombinant Rabbit Monoclonal Antibody [PS01-69]
Application: IHC-P,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
iFluor™ 488 Conjugated EpCAM Recombinant Rabbit Monoclonal Antibody [PS01-69]
Application: IF-Cell
Reactivity: Human
Conjugate: iFluor™ 488